Respiratory Care in Duchenne Muscular Dystrophy

Respiratory care in Duchenne muscular dystrophy is the planned surveillance and treatment of the breathing changes that develop as respiratory muscles weaken over the course of the disease. It includes pulmonary function testing, sleep studies, non-invasive ventilation, and airway clearance, coordinated by a pulmonologist with neuromuscular experience.

Breathing is one of the body systems DMD reaches in almost everyone, and one of the systems where modern care has changed survival the most. The combination of careful surveillance, non-invasive ventilation, and airway clearance has turned respiratory failure from the leading cause of early death into a manageable, monitored part of long-term care.

This post explains what respiratory care in DMD looks like, what it tracks, and what each common intervention is for.

Why breathing changes in DMD

DMD affects the muscles that move the chest and abdomen. The diaphragm, intercostal muscles, and abdominal muscles all contribute to inspiration, expiration, and the explosive force of a cough. As those muscles weaken, three things happen, often gradually.

Vital capacity declines. Cough becomes less effective. Sleep-time breathing becomes shallower, especially during REM sleep, when most respiratory muscles relax.

None of this is a sudden event. It is a slow trajectory that surveillance can read in time to act.

Lung function surveillance

The 2018 international care considerations describe respiratory assessment as a routine part of DMD care, with frequency increasing as the disease progresses. (Birnkrant et al., Lancet Neurology 2018, Part 2)

Typical monitoring includes forced vital capacity (FVC), peak cough flow, and oxygen saturation. As patients lose ambulation or as FVC declines below threshold values, the team adds sleep studies and overnight oximetry or capnography to detect nocturnal hypoventilation before symptoms appear.

The numbers themselves are not the goal. They are a way to plan ahead, so that interventions are introduced before a crisis rather than during one.

Sleep-disordered breathing

Many patients with DMD develop sleep-disordered breathing before they show daytime respiratory symptoms. The first signs can be subtle: morning headaches, daytime fatigue, poor concentration, restless sleep, or frequent waking. Some patients have no obvious symptoms at all and are picked up only on a routine sleep study.

A polysomnogram, or sleep study, can identify hypoventilation, obstructive events, and oxygen desaturation. Findings on a sleep study often guide the timing of nocturnal ventilation. (ATS Consensus Statement on Respiratory Care of the Patient with DMD)

Non-invasive ventilation

When nocturnal hypoventilation appears, the first step is usually bilevel positive airway pressure, often called BiPAP, delivered through a nasal or full-face mask at night. It supports each breath, reduces the work of the respiratory muscles, and corrects nighttime carbon dioxide retention.

Over time, some patients extend ventilation into the day, sometimes through a mouthpiece. Non-invasive ventilation has been associated with substantial survival gains compared to historical trajectories, and is recommended as the first-line approach before considering tracheostomy. (UK DMD respiratory care guidelines, PMC)

The transition to ventilation can feel large for families. In practice it is usually gradual, planned, and reversible at each step.

Airway clearance and cough assist

A weak cough is dangerous in DMD because secretions can accumulate during ordinary respiratory infections and turn a routine cold into pneumonia.

Manual techniques such as breath stacking and assisted cough are taught early. Mechanical insufflation-exsufflation devices, often called cough assist machines, deliver a positive pressure breath followed by rapid negative pressure to simulate a strong cough and clear secretions. (Birnkrant et al., Lancet Neurology 2018, Part 2)

Airway clearance is paired with ventilation, not a replacement for it. Together they account for much of the survival improvement in DMD over the past two decades.

Vaccinations and infection prevention

Respiratory infections can decompensate a patient with reduced reserve. Routine vaccinations, including annual influenza, COVID-19 boosters as recommended, and pneumococcal vaccines, are part of DMD care.

Early treatment of respiratory infections, with low threshold for antibiotics, antivirals, supplemental airway clearance, and ventilatory support, is standard practice.

When tracheostomy is considered

For most patients with DMD, non-invasive ventilation can sustain respiratory support for many years, even when daytime ventilation is needed.

Tracheostomy is considered only in specific situations, such as a failure of non-invasive ventilation to maintain adequate gas exchange, anatomical reasons that make masking impractical, or after specific acute events. The decision involves the patient, the family, the neuromuscular team, and pulmonology, with explicit attention to patient preferences and long-term quality of life.

What is still uncertain

Optimal timing of nocturnal ventilation, choice of interface, integration with cardiac surveillance, and how new disease-modifying therapies might slow respiratory decline are all active questions. Practice continues to evolve.

The reasonable framing is that respiratory care in DMD is one of the most successful examples of multidisciplinary management in pediatric neuromuscular disease. The decisions belong to the care team working with current information for the individual patient.

For related reading, see DMD standards of care, cardiac care in DMD, and DMD transition to adulthood.

Disclaimer: This post is informational and does not constitute medical advice. Decisions about diagnosis or treatment must be made with a qualified care team.